A separate meta-analysis focused on the methionine synthase (MTR) gene polymorphism A2756G (rs1805087), a common polymorphism thought to possibly lower MTR activity leading to lower methionine, suggested that there is no significant association between A2756G and breast cancer risk [33]. Here, MTR is linked to breast carcinoma.